Current Hypertension Reports

, Volume 12, Issue 5, pp 349–355

Masked Hypertension: Evidence of the Need to Treat

  • Gbenga Ogedegbe
  • Charles Agyemang
  • Joseph E. Ravenell
Article

DOI: 10.1007/s11906-010-0140-4

Cite this article as:
Ogedegbe, G., Agyemang, C. & Ravenell, J.E. Curr Hypertens Rep (2010) 12: 349. doi:10.1007/s11906-010-0140-4

Abstract

The diagnosis of masked hypertension has been made easier with the widespread availability of home blood pressure monitoring devices with levels of accuracy comparable to ambulatory blood pressure monitoring. The negative impact of masked hypertension on cardiovascular morbidity and mortality is evidenced by numerous well-designed clinic-based and population-based studies. The relationship of masked hypertension and target organ damage is also well documented. These two factors, combined with the robust evidence of reduced cardiovascular morbidity and mortality achieved with blood pressure treatment, makes the argument for actively identifying patients with masked hypertension and prescribing treatment similar to that for patients with sustained hypertension. In this paper, we review the evidence for the cardiovascular prognosis of masked hypertension compared with sustained hypertension, we review its impact on target organ damage, we propose an algorithm for the treatment of patients with masked hypertension, and we point out the pitfalls in adopting such an approach.

Keywords

Masked hypertension Out-of-office blood pressure measurement Ambulatory blood pressure monitoring Home blood pressure monitoring Self blood pressure measurement BP measurement Target organ damage Cardiovascular prognosis 

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Gbenga Ogedegbe
    • 1
  • Charles Agyemang
    • 1
  • Joseph E. Ravenell
    • 1
  1. 1.Center for Healthful Behavior Change, Division of General Internal MedicineNew York University School of MedicineNew YorkUSA

Personalised recommendations